Analyst ratings, especially from reputable firms like Evercore ISI Group, can significantly influence investor sentiment and stock prices. An Outperform rating suggests that the analyst believes RAPT Therapeutics' stock will perform better than the market or its sector, potentially leading to increased investor interest and a rise in stock price in the short term.